IL17A and rheumatoid arthritis: Although these authors did not report on absolute numbers of CD4+CD161+ cells, the reported percentages of IL-17 producing CD4+ CD161+ T-cells compare well with our data in late-stage RA (mean of 5% with ranges between 2-10%).